Evidence map›Paper›PMID 42655973›Full record

ArticleJournal of immunology research2026

Impaired Antiviral and Type 3 Immune Responses in Crush Injury Patients With Earthquake-Related Trauma.

Recep Civan Yuksel, Busra Seniz Demir, Mohammad Ahmad Houran, Mine Asan, Sahin Temel, Ahmet Safa Kaynar, Birkan Ulger, Tutkun Talih, Aliye Esmaoglu, Murat Sungur and 2 more

Abstract read
In one paragraph

Article in Journal of immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Recep Civan YukselDivision of Intensive Care, Department of Internal Medicine, School of Medicine, Erciyes University, Kayseri, Türkiye, erciyes.edu.tr.ORCID https://orcid.org/0000-0003-4496-9473
Busra Seniz DemirErciyes University, Faculty of Medicine, Department of Medical Biology, Kayseri, Türkiye, erciyes.edu.tr.ORCID https://orcid.org/0000-0002-2047-2967
Mohammad Ahmad HouranErciyes University, Faculty of Medicine, Department of Medical Biology, Kayseri, Türkiye, erciyes.edu.tr.ORCID https://orcid.org/0009-0000-8287-7073
Mine AsanErciyes University, Faculty of Medicine, Department of Medical Biology, Kayseri, Türkiye, erciyes.edu.tr.ORCID https://orcid.org/0009-0005-3532-3277
Sahin TemelDivision of Intensive Care, Department of Internal Medicine, School of Medicine, Erciyes University, Kayseri, Türkiye, erciyes.edu.tr.ORCID https://orcid.org/0000-0002-2766-4312
Ahmet Safa KaynarDivision of Intensive Care, Department of Internal Medicine, School of Medicine, Erciyes University, Kayseri, Türkiye, erciyes.edu.tr.ORCID https://orcid.org/0009-0003-2278-7668
Birkan UlgerDepartment of Anesthesiology and Reanimatio, Kayseri City Hospital, Ministry of Health, Kayseri, Türkiye, kayserisehir.saglik.gov.tr.ORCID https://orcid.org/0000-0002-7737-2553
Tutkun TalihDepartment of General Surgery, School of Medicine, Erciyes University, Kayseri, Türkiye, erciyes.edu.tr.ORCID https://orcid.org/0000-0003-3999-6733
Aliye EsmaogluDepartment of Anesthesiology and Reanimation, Division of Intensive Care, School of Medicine, Erciyes University, Kayseri, Türkiye, erciyes.edu.tr.ORCID https://orcid.org/0000-0002-8267-138X
Murat SungurDivision of Intensive Care, Department of Internal Medicine, School of Medicine, Erciyes University, Kayseri, Türkiye, erciyes.edu.tr.ORCID https://orcid.org/0000-0002-0011-3166
Kürşat GündoğanDivision of Intensive Care, Department of Internal Medicine, School of Medicine, Erciyes University, Kayseri, Türkiye, erciyes.edu.tr.ORCID https://orcid.org/0000-0002-8433-3480
Ahmet EkenErciyes University, Faculty of Medicine, Department of Medical Biology, Kayseri, Türkiye, erciyes.edu.tr.ORCID https://orcid.org/0000-0002-5816-0686

Funding

Erciyes University Scientific Research Projects Unit TSA-2024-13353
6 · The paper itself

Abstract

backgroundInfections are frequent in critically ill patients with earthquake-associated crush injury (CI) and contribute to poor outcomes, yet the immune pathways underlying posttrauma susceptibility remain poorly defined. We investigated longitudinal changes in damage-associated molecular pattern (DAMP)/PAMP sensing and downstream inflammatory programs in CI patients requiring intensive care.

methodsNineteen CI patients admitted to the ICU after the February 6, 2023 Kahramanmaraş earthquake and 18 age- and sex-matched healthy controls were enrolled. Peripheral blood was collected on hospital days 7 and 21. DAMP/PAMP receptor expression was assessed by flow cytometry and RT-qPCR, and pathway activation was evaluated by phospho-flow (pSTING, pIRF3, pNF-κB, and p-cJun) in gated lymphocytes and monocytes. Plasma cytokines/alarmins and select DAMPs were quantified by multiplex enzyme-linked immunosorbent assay (ELISA)/assays.

resultsCI patients demonstrated broad remodeling of nucleic acid-sensing programs, including reduced expression of TLR7, STING, and IRF7, with a discordant signaling pattern characterized by increased IRF3 phosphorylation, transiently reduced pSTING, and sustained reduction of p-cJun, while NF-κB activation remained comparatively stable. In plasma, IL-33 and IFN-α2 were reduced on Day 7, and type 3 immunity-associated cytokines IL-23 and IL-17A were significantly decreased by Day 21, consistent with impaired antimicrobial barrier-supporting responses. Circulating DAMPs were dynamically altered, with increased S100A9 and HMGB1 and decreased ATP following injury.

conclusionsEarthquake-associated CI is associated with dynamic DAMP release and dysregulated innate sensing accompanied by suppression of antiviral and type 3 immune cytokine programs. These immune alterations may contribute to heightened vulnerability to secondary infections in critically ill CI patients.

Indexed as

Crush SyndromeEarthquakesAdultAgedAlarminsCritical IllnessCytokinesFemaleHumansImmunity, InnateInnate Immunity RecognitionInterferon Regulatory Factor-3MaleMiddle AgedSignal TransductionAlarminsCytokinesInterferon Regulatory Factor-3alarmincrush injuryDAMPSearthquakeintensive careinterferontype 3 immunity

Identifiers

PMID42655973
PMCPMC13519304

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.